Article
Association between interleukin-18 promoter variants and tacrolimus pharmacokinetics in Chinese renal transplant patients.
European journal of clinical pharmacology - 1 Feb 2015
Xing Jiazhen, Zhang Xiaoqing, Fan Junwei, Shen Bin, Men Tongyi, Wang Jianning
Abstract excerpt
PURPOSE: Interleukin 18 (IL-18) is a potent proinflammatory cytokine thought to down-regulate cytochrome P450 (CYP) enzyme activities. This study aimed to assess the potential influence of two functional single nucleotide polymorphisms (SNPs) in the IL-18 promoter region on the tacrolimus pharmacokinetics in Chinese renal transplant patients. METHODS: We enrolled 96 renal allograft recipients receiving...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
